Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical

Jiangsu Zilong Pharmaceutical is a major subsidiary of the Yangtze River Pharmaceutical Group (YRPG), serving as a strategic high-tech production and R&D base in Changzhou, China. The company focuses on the development and large-scale manufacturing of innovative small molecules and high-end generic drugs across diverse therapeutic areas such as oncology, neurology, and cardiovascular health. Zilong Pharmaceutical operates state-of-the-art facilities that adhere to international GMP standards, supporting YRPG's broader mission of global expansion and therapeutic innovation. The company is instrumental in the group's transition from traditional chemical manufacturing to the production of complex biologics and targeted therapies. Its portfolio includes a mix of established commercial products and a growing pipeline of proprietary clinical-stage candidates.